Vaccines against neglected tropical diseases: Promising interventions to rescue the poorest populations in the Americas

Immunotherapy

Volumn 6, Issue 2, 2014, Pages 117-119

  Bottazzi, Maria Elena ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Latin America; neglected tropical disease; preventive vaccine; product development partnership; therapeutic vaccine

Indexed keywords

CARIBBEAN REGION; COST-BENEFIT ANALYSIS; FUND RAISING; INTERNATIONAL COOPERATION; LATIN AMERICA; MASS VACCINATION; NEGLECTED DISEASES; POVERTY AREAS; PRIVATE SECTOR; RESEARCH SUPPORT AS TOPIC; UNITED STATES; VACCINES;

EID: 84893872592     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.13.159     Document Type: Review

References (18)

1. Gindling TH. Poverty in Latin America. Latin Am. Res. Rev. 40(1), 207-222 (2005).
2. Shaefer HL, Edin K. Extreme poverty in the United States, 1996 to 2011. National Poverty Center Policy Brief 28. National Poverty Center, MI, USA (2012).
3. Hotez PJ. The Disease Next Door. Foreign Policy (2013) (Epub).
4. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373(9674), 1570-1575 (2009).
5. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl. Trop. Dis. 2(9), e300 (2008).
6. Murray CJ, Vos T, Lozano R et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2197-2223 (2012).
7. Hotez PJ, Dumonteil E, Heffernan MJ, Bottazzi ME. Innovation for the 'bottom 100 million': eliminating neglected tropical diseases in the Americas. Adv. Exp. Med. Biol. 764, 1-12 (2013).
8. Freeman MC, Ogden S, Jacobson J et al. Integration of water, sanitation, and hygiene for the prevention and control of neglected tropical diseases: a rationale for inter-sectoral collaboration. PLoS Negl. Trop. Dis 7(9), e2439 (2013).
9. Hotez PJ, Diemert D, Bacon KM et al. The human hookworm vaccine. Vaccine 31(Suppl. 2), B227-B232 (2013).
10. Lee BY, Bacon KM, Bailey R, Wiringa AE, Smith KJ. The potential economic value of a hookworm vaccine. Vaccine 29(6), 1201-1210 (2011).
11. Taylor K, Nguyen A, Stephenne J. The need for new vaccines. Vaccine 27(Suppl. 6), G3-G8 (2009).
12. Nabel GJ. Designing tomorrow's vaccines. N. Engl. J. Med. 368(6), 551-560 (2013).
13. Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME. New vaccines for neglected parasitic diseases and dengue. Transl. Res. 162(3), 144-155 (2013).
14. Bethony JM, Cole RN, Guo X. Vaccines to combat the neglected tropical diseases. Immunol. Rev. 239(1), 237-270 (2011).
15. Raw I, Higashi HG. Self-sufficiency and innovation in vaccine production and public health. Estud. Av. 22(64), 155-170 (2008).
16. Dumonteil E, Bottazzi ME, Zhan B et al. Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Rev. Vaccines 11(9), 1043-1055 (2012).
17. Lee BY, Bacon KM, Wateska AR, Bottazzi ME, Dumonteil E, Hotez PJ. Modeling the economic value of a Chagas' disease therapeutic vaccine. Hum. Vaccin. Immunother. 8(9), 1293-1301 (2012).
18. Bottazzi ME, Brown AS. Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm. Expert Rev. Vaccines 7(10), 1481-1492 (2008).